Liang L - Search Results

1

Unveiling the Power of Gut Microbiome in Predicting Neoadjuvant Immunochemotherapy Responses in Esophageal Squamous Cell Carcinoma.

Liu L, Liang L, Luo Y, Han J, Lu D, Cai R, Sethi G, Mai S. Liu L, et al. Among authors: liang l. Research (Wash D C). 2024 Nov 14;7:0529. doi: 10.34133/research.0529. eCollection 2024. Research (Wash D C). 2024. PMID: 39545038 Free PMC article.

2

Fusobacterium nucleatum Aggravates the Progression of Colitis by Regulating M1 Macrophage Polarization via AKT2 Pathway.

Liu L, Liang L, Liang H, Wang M, Lu B, Xue M, Deng J, Chen Y. Liu L, et al. Among authors: liang l, liang h. Front Immunol. 2019 Jun 12;10:1324. doi: 10.3389/fimmu.2019.01324. eCollection 2019. Front Immunol. 2019. PMID: 31249571 Free PMC article.

3

An engineering probiotic producing defensin-5 ameliorating dextran sodium sulfate-induced mice colitis via Inhibiting NF-kB pathway.

Zeng L, Tan J, Xue M, Liu L, Wang M, Liang L, Deng J, Chen W, Chen Y. Zeng L, et al. Among authors: liang l. J Transl Med. 2020 Mar 2;18(1):107. doi: 10.1186/s12967-020-02272-5. J Transl Med. 2020. PMID: 32122364 Free PMC article.

4

Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway.

Liu L, Liang L, Yang C, Zhou Y, Chen Y. Liu L, et al. Among authors: liang l. Gut Microbes. 2021 Jan-Dec;13(1):1-20. doi: 10.1080/19490976.2021.1902718. Gut Microbes. 2021. PMID: 33769187 Free PMC article.

5

Prevalence of celiac disease in China: Meta-analysis and serological survey in high-risk populations.

Zhou WY, Liu XY, Wang MM, Liang LP, Liu L, Zheng K, Silvester JA, Ma WJ, Wu W, Ji GY, Xu YJ, Xu XJ, Kelly CP, Chen Y. Zhou WY, et al. Among authors: liang lp. J Dig Dis. 2021 Nov;22(11):645-655. doi: 10.1111/1751-2980.13049. Epub 2021 Nov 3. J Dig Dis. 2021. PMID: 34482631 Review.

6

Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial.

Yang C, Liang L, Lv P, Liu L, Wang S, Wang Z, Chen Y. Yang C, et al. Among authors: liang l. Helicobacter. 2021 Dec;26(6):e12856. doi: 10.1111/hel.12856. Epub 2021 Oct 10. Helicobacter. 2021. PMID: 34628695 Clinical Trial.

7

Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage/WNT/ERK signaling pathway.

Liang L, Liu L, Zhou W, Yang C, Mai G, Li H, Chen Y. Liang L, et al. Clin Sci (Lond). 2022 Feb 25;136(4):291-307. doi: 10.1042/CS20210778. Clin Sci (Lond). 2022. PMID: 35194640

8

Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma.

Mai S, Liang L, Mai G, Liu X, Diao D, Cai R, Liu L. Mai S, et al. Among authors: liang l. Front Endocrinol (Lausanne). 2022 Mar 29;13:829175. doi: 10.3389/fendo.2022.829175. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35422758 Free PMC article.

9

Commensal bacteria-derived extracellular vesicles suppress ulcerative colitis through regulating the macrophages polarization and remodeling the gut microbiota.

Liang L, Yang C, Liu L, Mai G, Li H, Wu L, Jin M, Chen Y. Liang L, et al. Microb Cell Fact. 2022 May 16;21(1):88. doi: 10.1186/s12934-022-01812-6. Microb Cell Fact. 2022. PMID: 35578339 Free PMC article.

10

DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.

Liang L, Mai S, Mai G, Chen Y, Liu L. Liang L, et al. Front Endocrinol (Lausanne). 2022 Jul 26;13:882431. doi: 10.3389/fendo.2022.882431. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35957812 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,120 results

Search Page

Filters